Aurinia Pharmaceuticals
AUPH
AUPH
197 hedge funds and large institutions have $519M invested in Aurinia Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 64 increasing their positions, 48 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
197
Holders Change
+18
Holders Change %
+10.06%
% of All Funds
2.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
38
Increased
64
Reduced
48
Closed
18
Calls
$13.3M
Puts
$16.8M
Net Calls
-$3.54M
Net Calls Change
+$14.7M
Top Buyers
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
$75.7M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
$9.66M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
$7.63M |
| 4 |
Lazard Asset Management
New York
|
$5.36M |
| 5 |
JPMorgan Chase & Co
New York
|
$8.33M |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
$57.5M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
$0 |
| 3 |
Goldman Sachs
New York
|
$15.7M |
| 4 |
SG Americas Securities
New York
|
$562K |
| 5 |
Citadel Advisors
Miami,
Florida
|
$1.51M |
